ABOUT COMPANY
Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.
|
EARNINGS
Gross Profit (TTM): -3053000
Market Capitalization: 1748734000
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 0
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.564
Dividend Date: 2017-05-10
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -4572000
ExDividend Date: 2012-12-13
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|